I believe that Genova has 15000 clinicians. I remember Luke mentioning in a podcast that he is expecting at least 1 Microba kit sale per month per clinician which at A$90 per kit is $1,350,000 per month.
Geneva expects big things which is why they have invested in their own lab. They will promote to their 15000 clinicians and expect results. Once the lab is done with their work the data is sent to Microba in Brisbane for the IP protected algo to do its thing. It's about 90% profit margin to Microba.
It will probably take 6 months or so for Geneva to start reaching targets.
It's a brilliant model. Huge growth ahead.
I expect in years time we will be on a $20 mil plus run rate.
MAP Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
